Ipspine

chronic lower back pain (lbp) is a leading cause of disability and morbidity worldwide.. although there are many causes of lbp, one major cause is the degeneration of the spine’s intervertebral discs (ivds). this condition makes up around 40%, or 280 million, lbp cases. this leads to an economic burden in the eu of around ~€240 billion. despite the large impact, patients with this type of lbp only have a few options for treatment, such as pain relief medication and physiotherapy. if these don’t help, the last remaining option is invasive and costly surgery. there are no treatments yet that can stop or reverse this condition. the best potential treatment for chronic lbp is to address the pain and rejuvenate the degenerated tissue for long lasting effects. the ipspine partners, which include both universities and companies, joined together to begin researching a new, advanced therapy for the treatment of lbp caused by disc deterioration. the aim of this project is to investigate and de